• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXL00750 沙美特罗/丙酸氟替卡松干粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(4) New Drug Application 2000-11-20 北京哈里斯临床研究有限公司代理 Certificate Issued 2001-04-02 view
H20010069 沙美特罗干粉剂 salmeterol xinafoate Inhalation Chemical Drugs Import Drug Application 2001-04-06 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-07-25 view
CXS01227 沙美特罗气雾剂 salmeterol xinafoate Aerosol Chemical Drugs(4) New Drug Application 2001-07-27 山东省医药工业研究所山东鲁南制药厂 Certificate Issued 2004-07-05 view
CXS01226 沙美特罗 salmeterol xinafoate Active ingredient Chemical Drugs(4) New Drug Application 2001-07-27 山东省医药工业研究所山东鲁南制药厂 Certificate Issued 2004-07-05 view
B20010174 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Import Drug Application 2001-12-07 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2003-02-18 view
CXLb20020005 沙美特罗替卡松吸入粉剂(原名:沙美特罗/丙酸氟替卡松吸入粉剂) fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(4+5) Supplementary Application 2002-03-12 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2002-08-16 view
J0300146 羟萘酸沙美特罗 Salmeterol Hydroxynaphthoate Active ingredient Chemical Drugs License Renew 2003-02-24 GlaxoSmithKline (China) Investment Co Ltd Certificate Completed-Pending Issued 2003-07-28 view
J0300816 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2003-06-17 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2003-11-27 view
J0300818 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2003-06-17 GlaxoSmithKline (China) Investment Co Ltd Certificate Completed-Pending Issued 2003-11-14 view
J0300817 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2003-06-17 GlaxoSmithKline (China) Investment Co Ltd Certificate Completed-Pending Issued 2003-11-14 view
J0301261 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2003-08-29 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2004-02-09 view
J0301262 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2003-08-29 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2004-02-09 view
J0300958 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2003-10-30 GlaxoSmithKline Australia Ltd Glaxo Smithkline Australia Pty Ltd Certificate Completed-Pending Issued 2004-04-16 view
JYHB0500016 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2005-02-25 Certificate Issued 2005-08-31 view
JXHB0690005 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2006-05-16 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2003-08-29 view
JYHB0700934 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2007-09-12 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2008-05-27 view
JYHB0700936 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2007-09-12 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2008-05-27 view
JYHB0700935 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2007-09-12 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2008-05-27 view
JXHL0800008 噻托溴铵/沙美特罗粉吸入剂 salmeterol;tiotropium bromide Inhalation Chemical Drugs(1.5) Import Drug Application 2008-01-10 Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH Certificate Issued 2009-02-09 view
JYHB0900137 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2009-03-05 Glaxo Wellcome UK Limited Glaxo Wellcome Operations Certificate Issued 2009-10-22 view